11.70BMarket Cap37.12P/E (TTM)
63.220High62.320Low1.50MVolume62.450Open62.330Pre Close94.15MTurnover0.82%Turnover Ratio37.12P/E (Static)186.49MShares73.02152wk High8.19P/B11.52BFloat Cap59.63852wk Low1.79Dividend TTM183.64MShs Float83.608Historical High2.85%Div YieldTTM1.44%Amplitude2.190Historical Low62.689Avg Price1Lot Size
Equity Lifestyle Properties Inc Stock Forum
ColumnsUS Top Gap Ups and Downs on 7/20: NFLX, TSLA, INFY, ZION and More
Gap Ups
1. $Zions Bancorp(ZION.US)$ - up 4.0%
2. $Equity Lifestyle Properties Inc(ELS.US)$ - up 3.6%
3. $Novo-Nordisk A/S(NVO.US)$ - up 1.7%
4. $Freeport-McMoRan(FCX.US)$ - up 1.4%
5. $Orange SA(ORAN.US)$ - up 0.9%
6. $Sanofi(SNY.US)$ - up 0.9%
7. $Catalent(CTLT.US)$ - up 0.9%
8. $Tenaris(TS.US)$ - up 0.9...
AH + 7/18 Watchlist ⚡️⚡️
ColumnsBefore the Bell | Stock Futures Slipped Monday Ahead of a Busy Week for Corporate Earnings
ColumnsTop upgrades and downgrades on 7/15: QCOM, DAL, CSCO, DRE and more
• $Allogene Therapeutics(ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)
• $ChampionX(CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)
• $CSX Corp(CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)
•$TechnipFMC(FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)
• $Norfolk Southern(NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $2...
ColumnsTop upgrades and downgrades on 5/11
• $Arcturus Therapeutics(ARCT.US)$ : Baird Upgrades to Neutral from Underperform - PT $18 (from $21)
• $Arrowhead Pharmaceuticals(ARWR.US)$ : Baird Upgrades to Outperform from Neutral - PT $60 (from $71)
• $Cronos Group(CRON.US)$ : CIBC Upgrades to Outperformer from Neutral
• $HF Sinclair(DINO.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $52 (from $38)
• $8x8(EGHT.US)$ : B. Riley Upgrades to Buy from Neutral - PT $13.50
• $Novanta(NOVT.US)$ : William...
ColumnsToday's pre-market stock movers: PLUG, CMPI, JNJ, LMT and more
• $Checkmate Pharmaceuticals(CMPI.US)$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US)$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US)$ +14.3% (earnings report)
• $Plug Power(PLUG.US)$ +9.24% (t...
No comment yet